Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Retroviruses and Opportunistic Infections--Tenth Conference. 10-14 February 2003, Boston, MA, USA.
Virus entry as a target for anti-HIV intervention.
New antiretroviral drugs and approaches to HIV treatment.
Control of glycogen deposition.
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Reduced fitness of HIV-1 resistant to CXCR4 antagonists.
Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.
HIV protease inhibitors and dyslipidemia.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.